Celcuity Inc.

CELCNasdaqCIK 1603454HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 156 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Celcuity Inc., Reports and events
Filed	Form	What it is	Accession number
2021-08-1117:04 ET	10-Q	Quarterly reportPeriod 2021-06-30	0001654954-21-008769
2021-08-0916:16 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001654954-21-008635
2021-06-3010:13 ET	8-K	1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits	0001654954-21-007417
2021-05-1317:00 ET	8-K	5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results	0001654954-21-005626
2021-05-1017:17 ET	10-Q	Quarterly reportPeriod 2021-03-31	0001654954-21-005361
2021-05-1016:00 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001654954-21-005345
2021-04-0816:02 ET	8-K	1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits	0001654954-21-003990
2021-03-3116:00 ET	DEF 14A	Proxy statementPeriod 2021-05-12	0001654954-21-003623
2021-02-2416:30 ET	8-K	1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits	0001654954-21-002061
2021-02-1617:02 ET	10-K	Annual reportPeriod 2020-12-31	0001654954-21-001743
2021-02-1616:01 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001654954-21-001731
2020-11-0916:46 ET	10-Q	Quarterly reportPeriod 2020-09-30	0001654954-20-012025
2020-11-0916:11 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001654954-20-012010
2020-08-1117:00 ET	10-Q/A	Quarterly report, amendedPeriod 2020-06-30	0001654954-20-008876
2020-08-1017:23 ET	10-Q	Quarterly reportPeriod 2020-06-30	0001654954-20-008729
2020-08-1016:17 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001654954-20-008724
2020-06-0516:05 ET	8-K	1.01 Entry into a material agreement; 9.01 Financial statements and exhibits	0001654954-20-006352
2020-05-1516:30 ET	8-K	5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits	0001654954-20-005645
2020-05-0717:01 ET	10-Q	Quarterly reportPeriod 2020-03-31	0001654954-20-005065
2020-05-0717:00 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001654954-20-005066
2020-03-3115:30 ET	DEF 14A	Proxy statementPeriod 2020-05-14	0001654954-20-003602
2020-03-1312:58 ET	10-K	Annual reportPeriod 2019-12-31	0001654954-20-002595
2020-03-1216:43 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001654954-20-002564
2019-12-1207:27 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001654954-19-013833
2019-12-0516:30 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001654954-19-013637
2019-11-0716:46 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001654954-19-012490
2019-11-0716:46 ET	10-Q	Quarterly reportPeriod 2019-09-30	0001654954-19-012489
2019-08-0817:04 ET	10-Q	Quarterly reportPeriod 2019-06-30	0001144204-19-038618
2019-08-0817:00 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001144204-19-038611
2019-06-1716:30 ET	8-K	5.02 Departure or appointment of officers or directors	0001144204-19-031179
2019-05-2017:00 ET	8-K	5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits	0001144204-19-027333
2019-05-0717:04 ET	10-Q	Quarterly reportPeriod 2019-03-31	0001144204-19-024283
2019-05-0717:00 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001144204-19-024278
2019-04-0315:30 ET	DEF 14A	Proxy statementPeriod 2019-05-16	0001144204-19-017990
2019-03-0116:02 ET	10-K	Annual reportPeriod 2018-12-31	0001144204-19-011631
2019-02-2617:00 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001144204-19-010231
2018-11-1316:46 ET	10-Q	Quarterly reportPeriod 2018-09-30	0001144204-18-059399
2018-11-1316:21 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001144204-18-059377
2018-10-1917:20 ET	8-K	5.02 Departure or appointment of officers or directors	0001144204-18-054599
2018-08-0916:47 ET	10-Q	Quarterly reportPeriod 2018-06-30	0001144204-18-043344
2018-08-0916:16 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001144204-18-043302
2018-05-1608:29 ET	8-K	5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits	0001144204-18-029073
2018-05-1416:46 ET	10-Q	Quarterly reportPeriod 2018-03-31	0001144204-18-028226
2018-05-1416:15 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001144204-18-028195
2018-04-0616:49 ET	8-K	5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure	0001144204-18-019634
2018-03-2716:56 ET	DEF 14A	Proxy statementPeriod 2018-05-10	0001144204-18-017191
2018-03-1516:46 ET	10-K	Annual reportPeriod 2017-12-31	0001144204-18-014940
2018-03-1516:17 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001144204-18-014918
2017-12-0117:29 ET	10-Q/A	Quarterly report, amendedPeriod 2017-09-30	0001144204-17-061978
2017-11-1317:23 ET	10-Q	Quarterly reportPeriod 2017-09-30	0001144204-17-058480

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 20:37 ET. Listed shows no prices and gives no investment advice.